糖尿病性高血圧:治療薬のグローバル治験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Diabetic Hypertension Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Diabetic Hypertension 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Diabetic Hypertension to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Diabetic Hypertension to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Diabetic Hypertension 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Diabetic Hypertension Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Troikaa Pharmaceuticals Ltd. 31
Clinical Trial Overview of Troikaa Pharmaceuticals Ltd. 31
Sanofi 32
Clinical Trial Overview of Sanofi 32
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
Clinical Trial Overview of Top Institutes / Government 34
Jikei University School of Medicine 34
Clinical Trial Overview of Jikei University School of Medicine 34
Juntendo University School of Medicine 35
Clinical Trial Overview of Juntendo University School of Medicine 35
Graduate School of Medicine and Faculty of Medicine, The University of Tokyo 36
Clinical Trial Overview of Graduate School of Medicine and Faculty of Medicine, The University of Tokyo 36
Hospital Universitario Pedro Ernesto 37
Clinical Trial Overview of Hospital Universitario Pedro Ernesto 37
Saitama Medical University 38
Clinical Trial Overview of Saitama Medical University 38
Juntendo University 39
Clinical Trial Overview of Juntendo University 39
Osaka University 40
Clinical Trial Overview of Osaka University 40
University of Pavia 41
Clinical Trial Overview of University of Pavia 41
University of Southern Denmark 42
Clinical Trial Overview of University of Southern Denmark 42
Medical University of Vienna 43
Clinical Trial Overview of Medical University of Vienna 43
Five Key Clinical Profiles 44
Appendix 60
Abbreviations 60
Definitions 60
Research Methodology 61
Secondary Research 61
About GlobalData 62
Contact Us 62
Disclaimer 62
Source 62


【レポート販売概要】

■ タイトル:糖尿病性高血圧:治療薬のグローバル治験動向(2014年下半期)
■ 英文:Diabetic Hypertension Global Clinical Trials Review, H2, 2014
■ 発行日:2014年8月30日
■ 調査会社:GlobalData
■ 商品コード:GDHC2323CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。